{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:14:48Z","timestamp":1792498488788,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21am0101098"],"award-info":[{"award-number":["JP21am0101098"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016987","name":"Research Center for Biomedical Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H03997"],"award-info":[{"award-number":["17H03997"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K22486"],"award-info":[{"award-number":["19K22486"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bmc.2022.116792","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:32:20Z","timestamp":1651649540000},"page":"116792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis and structure\u2013activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonists"],"prefix":"10.1016","volume":"66","author":[{"given":"Nao","family":"Namba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Noguchi-Yachide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.116792_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2022.116792_b0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/JOE-09-0271","article-title":"Liver X receptor in cholesterol metabolism","volume":"204","author":"Zhao","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bmc.2022.116792_b0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR\u03b1","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2022.116792_b0020","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.272.6.3137","article-title":"Activation of The Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway","volume":"272","author":"Lehmann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bmc.2022.116792_b0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nature Rev Endocrinol"},{"key":"10.1016\/j.bmc.2022.116792_b0035","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR\u03b1","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2022.116792_b0040","doi-asserted-by":"crossref","first-page":"39438","DOI":"10.1074\/jbc.M105863200","article-title":"Characterization of the Human ABCG1 Gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein","volume":"276","author":"Kennedy","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0045","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.1074\/jbc.M109927200","article-title":"Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors \u03b1 and \u03b2","volume":"277","author":"Repa","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0050","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1074\/jbc.M111041200","article-title":"Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors","volume":"277","author":"Joseph","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bcp.2005.11.004","article-title":"Different roles of liver X receptor \u03b1 and \u03b2 in lipid metabolism: Effects of an \u03b1-selective and a dual agonist in mice deficient in each subtype","volume":"71","author":"Lund","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2022.116792_b0060","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1161\/CIRCHEARTFAILURE.114.001260","article-title":"Activation of Liver-X-Receptor \u03b1 But Not Liver-X-Receptor \u03b2 Protects Against Myocardial Ischemia\/Reperfusion Injury","volume":"7","author":"He","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.bmc.2022.116792_b0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/molecules22010088","article-title":"Ligands of Therapeutic Utility for the Liver X Receptors","volume":"22","author":"Komati","year":"2017","journal-title":"Molecules"},{"issue":"5299","key":"10.1016\/j.bmc.2022.116792_b0070","article-title":"Riccardin C: A natural product that functions as a liver X receptor (LXR)\u03b1 agonist and an LXR\u03b2 antagonist","volume":"579","author":"Tamehiro","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2022.116792_b0075","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1016\/j.tet.2011.06.018","article-title":"Efficient and diversity-oriented total synthesis of Riccardin C and application to develop novel macrolactam derivatives","volume":"67","author":"Iwashita","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2022.116792_b0080","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/jm3002394","article-title":"Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6Hdibenz[b, e]azepin-6-one skeleton","volume":"55","author":"Aoyama","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0085","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1021\/acs.jmedchem.7b00718","article-title":"Quest for novel chemical entities through incorporation of silicon in drug scaffolds","volume":"61","author":"Ramesh","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4155\/fmc-2016-0193","article-title":"Progress in the medicinal chemistry of silicon. \u2013C\/Si-Exchange and beyond","volume":"9","author":"Fujii","year":"2017","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0095","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1039\/C6MD00012F","article-title":"Expanding the chemical space of hydrophobic pharmacophores: Role of hydrophobic substructures in the development of novel transcription modulators","volume":"7","author":"Fujii","year":"2016","journal-title":"Med Chem Commum"},{"key":"10.1016\/j.bmc.2022.116792_b0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/jm3010114","article-title":"Organosilicon molecules with medicinal applications","volume":"56","author":"Franz","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.116792_b0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/ol052996u","article-title":"Platinum oxide catalyzed silylation of aryl halides with triethylsilane: an efficient synthetic route to functionalized aryltriethylsilanes","volume":"8","author":"Hamze","year":"2006","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2022.116792_b0110","first-page":"7784","article-title":"Facile synthesis of hypersilylated aromatic compounds by palladium-mediated arylation reaction","volume":"46","author":"Lesbani","year":"2010","journal-title":"ChemCommun"},{"key":"10.1016\/j.bmc.2022.116792_b0115","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1093\/emboj\/cdg456","article-title":"Crystal structure of the heterodimeric complex of LXR\u03b1 and RXR\u03b2 ligand-binding domains in a fully agonistic conformation","volume":"22","author":"Svensson","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2022.116792_b0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jmb.2003.10.033","article-title":"Crystal structure of the human liver X receptor \u03b2 ligand-binding domain in complex with a synthetic agonist","volume":"334","author":"Hoerer","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2022.116792_b0125","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity","volume":"16","author":"Morris","year":"2009","journal-title":"J Comput Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:29:11Z","timestamp":1778574551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622001845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":25,"alternative-id":["S0968089622001845"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116792","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and structure\u2013activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116792"}}